US-EN
Select Country

LATEST NEWS

Bracco Diagnostics Inc. Receives Innovative Technology Designation from Vizient for LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension for Contrast Echocardiography



Read more

 

First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON ® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use



Read more

TRUTH Study

Click here to learn about the TRUTH1 Study.
Reference 1. Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Zižka J, Colosimo C, Urbańczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann E, Hirai T, Frattini T, Kirchin MA, Pirovano G. Are There Differences between Macrocyclic Gadolinium Contrast Agents for Brain Tumor Imaging? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol with Gadoteridol (the TRUTH Study). AJNR Am J Neuroradiol. 2014 Oct 9. [Epub ahead of print]

Congress calendar

From June 23 to 26, 2016
Orlando, FL

SCCT

From June 25 to 26, 2016
Chicago, IL

AASLD

Educational Events

AIMS

Established to compare various clinical approaches for targeted diagnostic imaging.

Read more

BAMRIS

Designed to help physicians stay abreast of the latest changes and applications in magnetic resonance.

Read more